2-es típusú cukorbetegség: vizsgálatok itt: Finnország
11 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Helsinki, Jyväskylä, Kuopio, Tampere, Turku
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 2. fázisNot yet taking people in FinnországdApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
- Where
- Helsinki, Turku
- Életkor
- 18 év to 64 év
- People
- 36 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06072326 · EU 2026-525684-40-01 - No phaseTaking peopleRegular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients
- Where
- Tampere
- Életkor
- 18 év and over
- People
- 150
- Run by
- Wellbeing Services County of Pirkanmaa
See details and how to joinNCT06486012 - 3. fázisTaking peopleCOLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
- Where
- Helsinki
- Életkor
- 55 év to 80 év
- People
- 10 000 worldwide
- Run by
- Montreal Heart Institute
See details and how to joinNCT05633810 · EU 2024-516646-19-00 - No phaseTaking peopleNMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)
- Where
- Savonlinna
- Életkor
- 45 év to 55 év
- People
- 1400
- Run by
- University of Eastern Finland
See details and how to joinNCT07820800 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Helsinki
- Életkor
- 18 év to 99 év
- People
- 24 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - No phaseTaking peopleOutcomes-Based Health Program for Type 2 Diabetes
- Where
- Kuopio
- Életkor
- 35 év to 74 év
- People
- 200
- Run by
- Kuopio University Hospital
See details and how to joinNCT07322757 - No phaseCsak meghívásosNutrition Apps in Occupational Healthcare (Pilot Study of the FOODNUTRI Project)
- Where
- Kuopio
- Életkor
- 18 év to 75 év
- People
- 204
- Run by
- University of Eastern Finland
See details and how to joinNCT06923735 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Helsinki
- Életkor
- 18 év to 100 év
- People
- 10 000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseCsak meghívásosCost-effectiveness of the Care Pathways
- Where
- Tampere
- Életkor
- 18 év to 90 év
- People
- 2500
- Run by
- Tampere University Hospital
See details and how to joinNCT04619836 - No phaseTaking peopleSTOP DIABETES - Knowledge-based Solutions
- Where
- Kuopio
- Életkor
- 18 év to 70 év
- People
- 10 000
- Run by
- University of Eastern Finland
See details and how to joinNCT03156478